[Skip to Navigation]
Sign In

Featured Clinical Reviews

August 2, 1884


JAMA. 1884;III(5):136. doi:10.1001/jama.1884.02390540024011

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The Patent Medicine Stamp Act—the English Board of Inland Revenue Decision against Nostrums, Specifics, and Legitimate Foreign Drugs.

London, July 14, 1884.

The recent decision of the Board of Inland Revenue against legitimate foreign drugs, as well as all patent medicine, has caused great dissatisfaction among both the medical and pharmaceutical professions throughout the Kingdom. It appears that the action of the Board was made specially upon the medicinal preparations of Park, Davis & Co., many of which are now being largely used in Great Britain. The Stamp Act of 1812, which has thus been unjustly interpreted by the board against the profession of this country, was in vogue when both pharmacy and medicine were in their infancy. English pharmacists and physicians no longer depend upon their own home products for fine preparations and good therapeutic results, but upon the valued remedies obtained from all parts of the world. In

First Page Preview View Large
First page PDF preview
First page PDF preview
Add or change institution